Danhong Injection in the Treatment of Chronic Stable Angina
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 920 participants.
Also called NCT01681316
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 920 participants
- Registry
-
NCT01681316
-
- Other papers using this trial's data
- Detection of an anti-angina therapeutic module in the effective population treated by a multi-target drug Danhong injection: a randomized trial
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- China
- Registry status
- Completed
Technical summary
Registry record NCT01681316. Randomized; quadruple masking; primary purpose treatment. Start 2012-12 (registry gives no type); primary completion 2016-10 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Danhong Injection in the Treatment of Chronic Stable Angina
- Condition
- Chronic Stable Angina
- Intervention (Drug)
- Danhong injection
- Intervention (Other)
- Standard medical care
- Intervention (Drug)
- Placebo
- Lead sponsor
- China Academy of Chinese Medical Sciences
- Collaborator
- China Food and Drug Administration
Record details
- Record id
cardio:ct-nct01681316- Content hash
239dbe3a6cefb0a352bca9e3a65a480dd85600713281ef45d9bc5681c2ac5e7d